[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 112,550
Sort by:

Desmoid Tumors Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major desmoid tumors markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.61% d...

May 2024 140 pages

Diabetic Foot Ulcers Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic foot ulcers markets reached a value of US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.4 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 134 pages

Diabetic Ketoacidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic ketoacidosis markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The diabetic ketoacidosis market has been comprehensively analyzed in IMARC's new report titled 'Dia...

May 2024 133 pages

Diabetic Macular Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic macular edema market reached a value of US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.5 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 138 pages

Diabetic Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic nephropathy markets reached a value of US$ 9,717.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14,572.9 Million by 2034, exhibiting a growth rate (C...

May 2024 134 pages

Diabetic Neuropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic neuropathy markets reached a value of US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5....

May 2024 131 pages

Diabetic Peripheral Neuropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diabetic peripheral neuropathy markets reached a value of US$ 2,903.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,365.9 Million by 2034, exhibiting a growt...

May 2024 134 pages

Diffuse Intrinsic Pontine Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diffuse intrinsic pontine glioma markets reached a value of US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.4 Billion by 2034, exhibiting a growth rate...

May 2024 130 pages

DiGeorge Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diGeorge syndrome markets are expected to exhibit a CAGR of 4.78% during 2024-2034. The DiGeorge Syndrome market has been comprehensively analyzed in IMARC's new report titled 'DiGeorge Sy...

May 2024 134 pages

Diphtheria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major diphtheria markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The diphtheria market has been comprehensively analyzed in IMARC's new report titled 'Diphtheria Market: Epidem...

May 2024 138 pages

Donohue Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Donohue syndrome markets reached a value of US$ 11.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 22.6 Billion by 2034, exhibiting a growth rate (CAGR) of 6.0...

May 2024 129 pages

Doose Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major doose syndrome markets reached a value of US$ 687.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,160.7 Million by 2034, exhibiting a growth rate (CAGR) of 1...

May 2024 136 pages

Down Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major down syndrome markets reached a value of US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 10.91% d...

May 2024 137 pages

Dravet Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Dravet syndrome markets reached a value of US$ 375.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 796.3 Million by 2034, exhibiting a growth rate (CAGR) of 7....

May 2024 135 pages

Drug-Resistant Epilepsy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major drug-resistant epilepsy markets reached a value of US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6.0 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 137 pages

Dry Age Macular Degeneration Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dry age macular degeneration markets are expected to exhibit a CAGR of 4.64% during 2024-2034. The dry age macular degeneration market has been comprehensively analyzed in IMARC's new repo...

May 2024 136 pages

Dupuytren's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Dupuytren's disease markets are expected to exhibit a CAGR of 3.76% during 2024-2034. The Dupuytren's disease market has been comprehensively analyzed in IMARC's new report titled 'Dupuytr...

May 2024 136 pages

Dysautonomia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysautonomia markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.5 Billion by 2034, exhibiting a growth rate (CAGR) of 9.22% dur...

May 2024 131 pages

Dyskinesia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyskinesia markets are expected to exhibit a CAGR of 3.14% during 2024-2034. The dyskinesia market has been comprehensively analyzed in IMARC's new report titled 'Dyskinesia Market: Epidem...

May 2024 130 pages

Dyslipidemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyslipidemia markets reached a value of US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.8 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% dur...

May 2024 133 pages

Dysmenorrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysmenorrhea markets reached a value of US$ 10.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.44% d...

May 2024 128 pages

Dyspepsia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyspepsia markets are expected to exhibit a CAGR of 3.49% during 2024-2034. The dyspepsia market has been comprehensively analyzed in IMARC's new report titled 'Dyspepsia Market: Epidemiol...

May 2024 128 pages

Dyspnea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyspnea markets are expected to exhibit a CAGR of 5.24% during 2024-2034. The dyspnea market has been comprehensively analyzed in IMARC's new report titled 'Dyspnea Market: Epidemiology, I...

May 2024 132 pages

Dyssomnias Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dyssomnias markets reached a value of US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.3 Billion by 2034, exhibiting a growth rate (CAGR) of 1.68% dur...

May 2024 139 pages

Dysthymia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major dysthymia markets are expected to exhibit a CAGR of 3.7% during 2024-2034. The dysthymia market has been comprehensively analyzed in IMARC's new report titled 'Dysthymia Market: Epidemiolo...

May 2024 130 pages

Dystrophic Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major dystrophic epidermolysis bullosa markets reached a value of US$ 525.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,857.8 Million by 2034, exhibiting a growt...

May 2024 132 pages

Eczema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eczema markets reached a value of US$ 16.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 37.1 Billion by 2034, exhibiting a growth rate (CAGR) of 7.46% during...

May 2024 136 pages

Edward’s Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Edward’s syndrome markets reached a value of US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.6 Billion by 2034, exhibiting a growth rate (CAGR) of 7.51...

May 2024 128 pages

EGFR Inhibitors-Induced Skin Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major EGFR inhibitors-induced skin disorders markets are expected to exhibit a CAGR of 17.89% during 2024-2034. The EGFR inhibitors-induced skin disorders market has been comprehensively analyze...

May 2024 135 pages

Ehlers-Danlos Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Ehlers-Danlos syndrome markets are expected to exhibit a CAGR of 3.42% during 2024-2034. The Ehlers-Danlos syndrome market has been comprehensively analyzed in IMARC's new report titled 'E...

May 2024 138 pages

Emesis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major emesis markets are expected to exhibit a CAGR of 4.18% during 2024-2034. The emesis market has been comprehensively analyzed in IMARC's new report titled 'Emesis Market: Epidemiology, Indu...

May 2024 140 pages

Emphysema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major emphysema markets reached a value of US$ 3.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.84% during...

May 2024 137 pages

Encephalitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major encephalitis markets reached a value of US$ 15.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1% du...

May 2024 137 pages

End-Stage Renal Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major end-stage renal disease markets reached a value of US$ 76.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 218.2 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 137 pages

Endocarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major endocarditis markets are expected to exhibit a CAGR of 4.22% during 2024-2034. The endocarditis market has been comprehensively analyzed in IMARC's new report titled 'Endocarditis Market:...

May 2024 131 pages

Endometrial Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major endometrial cancer markets reached a value of US$ 20.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 133 pages

Eosinophilia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eosinophilia markets reached a value of US$ 289.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 474.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.61%...

May 2024 131 pages

Eosinophilic Esophagitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major eosinophilic esophagitis markets reached a value of US$ 896.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7,604.7 Million by 2034, exhibiting a growth rate (...

May 2024 137 pages

Ependymoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ependymoma markets are expected to exhibit a CAGR of 4.03% during 2024-2034. The ependymoma market has been comprehensively analyzed in IMARC's new report titled 'Ependymoma Market: Epidem...

May 2024 131 pages

Epidermolysis Bullosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epidermolysis bullosa markets reached a value of US$ 2,596.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,929.8 Million by 2034, exhibiting a growth rate (C...

May 2024 131 pages

Epilepsy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epilepsy markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.5 Billion by 2034, exhibiting a growth rate (CAGR) of 2.35% during...

May 2024 140 pages

Epithelial Ovarian Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major epithelial ovarian cancer markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.3 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 134 pages

Erdheim-Chester Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Erdheim-Chester disease markets are expected to exhibit a CAGR of 7.13% during 2024-2034. The Erdheim-Chester disease market has been comprehensively analyzed in IMARC's new report titled...

May 2024 135 pages

Erectile Dysfunction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erectile dysfunction markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6...

May 2024 133 pages

Erosive Esophagitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erosive esophagitis markets are expected to exhibit a CAGR of 19.2% during 2024-2034. The erosive esophagitis market has been comprehensively analyzed in IMARC's new report titled 'Erosive...

May 2024 129 pages

Erythema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erythema markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The erythema market has been comprehensively analyzed in IMARC's new report titled 'Erythema Market: Epidemiology...

May 2024 137 pages

Erythromelalgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erythromelalgia markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.94%...

May 2024 132 pages

Esophageal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal cancer markets reached a value of US$ 9.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.7...

May 2024 137 pages

Esophageal Motility Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal motility disorders markets are expected to exhibit a CAGR of 5.93% during 2024-2034. The esophageal motility disorders market has been comprehensively analyzed in IMARC's new re...

May 2024 130 pages

Esophageal Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal squamous cell carcinoma markets are expected to exhibit a CAGR of 8.1% during 2024-2034. The esophageal squamous cell carcinoma market has been comprehensively analyzed in IMARC...

May 2024 133 pages

Filters

Search

Categories

370
94
242
550
1,143
110,057
94

Publishers

179
1
100
32
25
102
94
2,211
109
23
40
8,299
68
562
988
34
29,954
248
501
3,036
1
1
2
3
1
16
257
537
361
106
1
1,357
2,180
60
1,696
8
8,921
1,697
4
3,714
983
19
1
321
4,852
2,748
66
1
3
3
36
202
2,355
246
53
50
45
46
29
29
143
56
42
83
9
20
29
5
11
3
16,308
3
270
11
3
292
22
4
39
1
2
6,125
14
1
183
49
359
30
33
4,348
13
1
44
2
7
10
9
12
18
21
168
52
8
3
18
16
7
1
18
1
41
58
350
1
4
6
1
3
9
1
3
5
1
1
1
90
2
3
4
1
77
15
980
1
3
1
17
227
128
16
4
412
3
74
2
6
5
10
1
3
118
33
336
196
47
474
7
45
1
22
13
138
2
4

Regions

58
48
35
31
30
29
29
26
26
23
22
22
22
21
16
15
14
6
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
36
57
41
54
60
101
26
30
55
3
34
2
2
1,179
115
172
26
33
94
14
49
53
28
18
62
25
23
39
23
43
24
14
51
28
38
132
48
65
67
204
52
17
56
42
31
48
47
37
36
19
62
150
34
31
30
17
17
16
14
136
57
49
30
15
457
1,819
71
1,614
921
765
184
2,008
99,858

Price

Date

Pages

Offers

93
23
905
1
2,735
269
1
1